155 related articles for article (PubMed ID: 32368012)
1. Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells.
Yu XX; Ge KL; Liu N; Zhang JY; Xue ML; Ge YL
Drug Des Devel Ther; 2020; 14():1535-1545. PubMed ID: 32368012
[TBL] [Abstract][Full Text] [Related]
2. Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma.
Lu B; Wang J; Zhang J; Zhang X; Yang D; Wu L; Luo Z; Ma Y; Zhang Q; Ma Y; Pei X; Yu H; Liu J
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):128-35. PubMed ID: 24300391
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection and characterization of a DNA aptamer targeted to Prorocentrum minimum-A common harmful algae.
Liu F; Zhang C; Duan Y; Ma J; Wang Y; Chen G
Sci Total Environ; 2022 Jul; 830():154771. PubMed ID: 35339548
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC
Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292
[TBL] [Abstract][Full Text] [Related]
5. Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma.
Ninomiya K; Kaneda K; Kawashima S; Miyachi Y; Ogino C; Shimizu N
Bioorg Med Chem Lett; 2013 Mar; 23(6):1797-802. PubMed ID: 23403083
[TBL] [Abstract][Full Text] [Related]
6. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
7. Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.
Xu J; Teng IT; Zhang L; Delgado S; Champanhac C; Cansiz S; Wu C; Shan H; Tan W
PLoS One; 2015; 10(5):e0125863. PubMed ID: 25938802
[TBL] [Abstract][Full Text] [Related]
8. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma.
Lo CW; Chan CKW; Yu J; He M; Choi CHJ; Lau JYW; Wong N
Nanotheranostics; 2022; 6(2):161-174. PubMed ID: 34976591
[No Abstract] [Full Text] [Related]
9. An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.
Zhou G; Da Won Bae S; Nguyen R; Huo X; Han S; Zhang Z; Hebbard L; Duan W; Eslam M; Liddle C; Yuen L; Lam V; Qiao L; George J
Cancer Lett; 2021 Mar; 501():124-132. PubMed ID: 33352247
[TBL] [Abstract][Full Text] [Related]
10. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
11. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
12. Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX.
Cao HY; Yuan AH; Shi XS; Chen W; Miao Y
Oncol Rep; 2014 Nov; 32(5):2054-60. PubMed ID: 25175855
[TBL] [Abstract][Full Text] [Related]
13. Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential.
Chen H; Yuan CH; Yang YF; Yin CQ; Guan Q; Wang FB; Tu JC
Biomed Res Int; 2016; 2016():5735869. PubMed ID: 27119081
[TBL] [Abstract][Full Text] [Related]
14. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for
Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207
[TBL] [Abstract][Full Text] [Related]
15. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model.
Zhou K; Huo X; Nguyen R; Bae SDW; Han S; Zhang Z; Duan W; Yuen L; Lam V; George J; Qiao L
J Control Release; 2022 Jan; 341():341-350. PubMed ID: 34848243
[TBL] [Abstract][Full Text] [Related]
17. [DNA aptamer selection in vitro for determining ketamine by FluMag-SELEX].
Sun MQ; Cao FQ; Hu XL; Zhang YR; Lu XW; Zeng LB
Fa Yi Xue Za Zhi; 2014 Oct; 30(5):346-9. PubMed ID: 25735070
[TBL] [Abstract][Full Text] [Related]
18. Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.
Wan J; Ye L; Yang X; Guo Q; Wang K; Huang Z; Tan Y; Yuan B; Xie Q
Analyst; 2015 Sep; 140(17):5992-7. PubMed ID: 26181902
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX.
Fellows T; Ho L; Flanagan S; Fogel R; Ojo D; Limson J
Analyst; 2020 Aug; 145(15):5180-5193. PubMed ID: 32567629
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
Xiao S; Liu Z; Deng R; Li C; Fu S; Chen G; Zhang X; Ke F; Ke S; Yu X; Wang S; Zhong Z
J Control Release; 2017 Jul; 258():130-145. PubMed ID: 28522194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
